Notice

We use cookies to constantly improve our internet content and to create internal assessments pursuant to our data protection guidelines.

Further information

OK

LINC 2015 Programme

Find all topics and speakers listed below.

Main Arena 1

22 events
  • Tuesday, January 27th: - , Main Arena 1

    Symposium: Enhancing treatment in SFA & Pop lesions subsets with SUPERA

    Chairman:
    Dierk Scheinert
    Moderator:
    Ramon Varcoe, Steven Kum, Chris Metzger, Peter Goverde
    1. -

      Introduction by the chairman

    2. -

      SUPERB – 3 year follow up

        Lawrence Garcia
    3. -

      SUPERA data – long-term follow up/5 years

        Dierk Scheinert
    4. -

      Evolving strategies and economic considerations in treatment of femoropopliteal arterial disease

        Michael Jaff
    5. -

      A real world experience using SUPERA in long challenging lesions: patency results, deployment pitfalls and insights into mode of failure

        Ramon Varcoe
    6. -

      Optimal implantation deployment for optimal clinical outcome

        Chris Metzger
    7. -

      Live case transmission from Leipzig

    8. -

      The great debate: So many technologies – what is the optimal treatment for the SFA? (atherectomy, DCB, SNS, Covered, DES, SUPERA etc.)

  • Tuesday, January 27th: - , Main Arena 1

    Changing paradigms and future concepts in peripheral interventions

    Chairman:
    Dierk Scheinert, Gary Ansel
    Moderator:
    Karl-Ludwig Schulte, Steven Kum, Erich Minar, Andrew Holden, Michael Jaff, Iris Baumgartner
    1. -

      Drug-coated balloons: Finally proven as the first-line therapy for femoro-popliteal de-novo lesions?

    2. -

      In.Pact-SFA clinical trial: Update on 1-year data

        Gunnar Tepe
    3. -

      LEVANT II clinical trial: 2-year data

        Dierk Scheinert
    4. -

      My take-home messages from LEVANT II and In.Pact SFA – a critical review

        Michael Jaff
    5. -

      Panel discussion and vote

    6. -

      Live case transmission from Leizpig part I

    7. -

      Future prospects for DCB and alternative endovascular concepts

    8. -

      DCB + atherectomy: The ISAR STATH trial results

        Massimiliano Fusaro
    9. -

      DCB + atherectomy for complex lesions: DEFINETIVE AR – Final data

        Gunnar Tepe
    10. -

      Early look at the VISION Trial: OCT guided atherectomy using Avinger's Pantheris catheter

        Arne Schwindt
    11. -

      The role of vessel preparation – insights from the Heidelberg PANTHER registry

        Erwin Blessing
    12. -

      A future concept for drug delivery: The Mercator Bullfrog technology

        Dierk Scheinert
    13. -

      Live case transmission from Leipzig part II

    14. -

      Should all stents promote swirling flow?

        Thomas Zeller
    15. -

      The TOBA-trial 12 months results with the Tack-device for dissection sealing in the SFA

        Marc Bosiers
    16. -

      Biodegradable vascular scaffolds – how far have we come?

        Iris Baumgartner
  • Tuesday, January 27th: - , Main Arena 1

    Symposium: Drug-eluting technologies – the final 5 year conclusions. The guide to drug-elution and how to keep SFA treatment simple

    Chairman:
    Michael Dake
    Moderator:
    Konstantinos Katsanos, Fabrizio Fanelli, Andrew Holden
    1. -

      Introduction by the chairman

    2. -

      Zilver PTX – 5 year results

        Michael Dake
    3. -

      A treatment algorithm for drug eluting technologies

        Konstantinos Katsanos
    4. -

      Live case transmission from Leipzig

    5. -

      How I use drug-eluting devices in my practice

        Andrew Holden
    6. -

      Live case transmission from Dendermonde

    7. -

      Zilver PTX made easy

        Fabrizio Fanelli
    8. -

      Discussion and conclusion

  • Tuesday, January 27th: - , Main Arena 1

    Lunch

  • Tuesday, January 27th: - , Main Arena 1

    Symposium: DCB setting the stage for standard of care – an evidence-based review

    Chairman:
    Erich Minar
    Moderator:
    Peter Gaines, Gunnar Tepe, Gary Ansel, Hans Krankenberg, William Gray
    1. -

      IN.PACT in fem-pop TASC A-B and diabetics

        Gunnar Tepe
    2. -

      Live case transmission from Leipzig

    3. -

      IN.PACT global sub-analysis update: TASC C-D lesions

        Gary Ansel
    4. -

      DCB and ISR: Insights from FAIR study

        Hans Krankenberg
    5. -

      Are all DCB equal?

        William Gray
    6. -

      Live case transmission from Cotignola

    7. -

      IN.PACT role in SFA: Critical overview of modern endovascular therapies

        Frank Vermassen
  • Tuesday, January 27th: - , Main Arena 1

    Current concepts and advances for long femoropopliteal lesions and in-stent restenosis

    Chairman:
    Tony Das
    Moderator:
    Jörn Balzer, Francesco Liistro, Peter Gaines, Marc Bosiers, Sabine Steiner, Michael Werk, Roberto Gandini
    1. -

      What works best for long SFA disease? A review of the evidence

        Marc Bosiers
    2. -

      After 10.000+ DCB: How has this technology changed our clinical practice for complex SFA lesions?

        Andrej Schmidt
    3. -

      One-year follow-up of the DEBAS STUDY

        Patrice Mwipatayi
    4. -

      Is the combination of DCB and bare metal stents as effective as DES? The BIOLUX 4EVER trial

        Marc Bosiers
    5. -

      Live case transmission from Dendermonde

    6. -

      The endoluminal bypass – the best solution for long lesions and ISR?

        Peter Soukas
    7. -

      The Leipzig experience with DCB, conventional, and interwoven nitinol stents for complex SFA disease

        Sabine Steiner
    8. -

      Live case transmission from Leipzig

    9. -

      Excimer laser atherectomy for in-stent restenosis: Results of the EXCITE trial

        Eric Dippel
    10. -

      The Copa Cabana study: DEB vs. POBA in in-stent restenosis

        Gunnar Tepe
    11. -

      The cost economic value of DCB

        Konstantinos Katsanos
  • Tuesday, January 27th: - , Main Arena 1

    Scrub in with the experts: Solutions for severely calcified lesions, ISR and beyond

    live from Leipzig:
    Sven Bräunlich, Andrej Schmidt
    Chairman:
    Lawrence Garcia
    Moderator:
    Steve Ramee, Hermann Steinkamp, Andrew Holden, Ramon Varcoe, Miguel Montero-Baker, Sebastian Sixt
    1. -

      The Shockwave lithoplasty concept – finally the solution for calcified lesions?

        Andrew Holden
    2. -

      Our experience with biomimetic stent technology for severely calcified long lesions

        Donald Jacobs
    3. -

      The challenge of vessel calcification in different vascular beds: What are we dealing with?

        Jihad Mustapha
  • Wednesday, January 28th: - , Main Arena 1

    Symposium: Mechanical removal of occlusion material from arteries and veins – the new standard treatment?

    Chairman:
    Dierk Scheinert
    Moderator:
    Steven Kum, Michael Lichtenberg, Thomas Heller, Samuel Heller, Eberhard Wedell, Bruno Freitas
    1. -

      Introduction by the chairman

    2. -

      Rotarex mechanical debulking: The Leipzig experience in 1.200+ patients

        Dierk Scheinert
    3. -

      Live case transmission from Leipzig

    4. -

      Successful recanalisation of venous occlusions with Aspirex mechanical thrombectomy. The 50-cases-experience

        Michael Lichtenberg
    5. -

      Live case transmission from Leipzig

    6. -

      In-stent reocclusion: Why do we use mechanical debulking as first treatment step?

        Bruno Freitas
    7. -

      Discussion and conclusion

  • Wednesday, January 28th: - , Main Arena 1

    Critical limb ischemia treatment 2014: Lessons learned, current status and future perspectives

    Chairman:
    Dierk Scheinert, Peter Schneider
    Moderator:
    Iris Baumgartner, Renu Virmani, Andrew Holden, Yoshiaki Yokoi, Michael Jaff
    1. -

      The rationale for the “Endovascular First” concept and how to implement it

        Peter Schneider
    2. -

      Real world CLI practice: Update from the CRITISCH registry

        Theodosios Bisdas
    3. -

      The Angiosome concept: Pro and cons

    4. -

      The BEST-CLI Trial: Open vs. endovascular therapy for critical limb ischemia

        Michael Jaff
    5. -

      Revascularization of the wound-related artery is key

        Osamu Iida
    6. -

      Live case transmission from Leipzig part I

    7. -

      There is no proof for the angiosome concept

        Peter Huppert
    8. -

      Panel discussion and vote

    9. -

      Drug-coated balloons for BTK disease in critical limb ischemia – a failed concept?

    10. -

      One year after In.Pact Deep: Lessons learned from a failed trial

        Thomas Zeller
    11. -

      Safety of Paclitaxel balloon coatings: Insights from a pathologist

        Renu Virmani
    12. -

      Ongoing trials and future concepts for local drug delivery in BTK arteries

        Dierk Scheinert
    13. -

      Panel discussion and vote

    14. -

      Live case transmission from Leipzig part II

    15. -

      Destiny II: 12 months results with long segment DES treatment in BTK arteries

        Marc Bosiers
    16. -

      PES BTK 70: 12 months results with a paclitaxel-coated self-expandingstent in BTK arteries

        Marc Bosiers
    17. -

      Initial experience with absorbable drug-eluting vascular scaffolds in BTK arteries

        Ramon Varcoe
  • Wednesday, January 28th: - , Main Arena 1

    Symposium: Unique technologies for the treatment of peripheral artery disease

    Chairman:
    Michel Reijnen
    Moderator:
    Eric Verhoeven
    1. -

      Introduction by the chairman

    2. -

      Endovascular treatment with the new generation stent design of the GORE® TIGRIS® Vascular Stent

        Konstantinos Katsanos
    3. -

      Live case transmission from Dendermonde

    4. -

      Collateral damage in endovascular treatment of SFA occlusive disease: fact or fiction?

        Rombout Kruse
    5. -

      Live case transmission from Leipzig

    6. -

      Revising dysfunctional and thrombosed dialysis access: my experiences and clinical outcome

        Christian Hohl
    7. -

      Discussion and conclusion by the chairman

  • Wednesday, January 28th: - , Main Arena 1

    Lunch symposium: Endovascular procedures – how to choose the right device for complex procedures

    Chairman:
    Dierk Scheinert
    Moderator:
    Patrick Bagan, Konstantinos Donas, Michel Reijnen
    1. -

      Introduction by the chairman

    2. -

      Local drug delivery for acute occlusions in the peripheral arteries

        Patrick Bagan
    3. -

      Performance of renal covered stents in the endovascular treatment of pararenal pathologies

        Konstantinos Donas
    4. -

      Live case transmission from Leipzig

    5. -

      When not to use a bare metal stent – when not to use a covered stent for iliac stenotic lesions

        Michel Reijnen
    6. -

      Discussion and conclusion by the chairman

  • Wednesday, January 28th: - , Main Arena 1

    Symposium: Lutonix® DCB – Discussion on pre-clinical saftey studies, new insights from LEVANT2, Real World experience and the role of DCB in treatment of critical limb ischemia

    Chairman:
    Michael Jaff
    Moderator:
    Renu Virmani, Marcus Thieme, Marianne Brodmann, Jihad Mustapha
    1. -

      Not all DCBs are created equal: Side by side pre-clinical safety evaluation of leading DCBs

        Renu Virmani
    2. -

      Live case transmission from Leipzig

    3. -

      New insights from LEVANT2: Randomized 12 month data and post hoc analysis

        Dierk Scheinert
    4. -

      A first look and interim analysis of 12 month outcomes from the Real World Global SFA registry

        Marcus Thieme
    5. -

      Live case transmission from Leipzig

    6. -

      Role of DCBs in treating critical limb ischemia and the enrollment update on-going Lutonix® BTK clinical trial

        Marianne Brodmann
    7. -

      Discussion on physiology of CLI in utility of DCB in below-the-knee procedures

        Jihad Mustapha
    8. -

      German single center experience with Lutonix® DCB in BTK

        Sabine Steiner
  • Wednesday, January 28th: - , Main Arena 1

    VIVA @ LINC: Renal and visceral disease: pressing new dilemmas and pushing the field forward

    Chairman:
    Chris Metzger
    Moderator:
    Michael Jaff, Tony Das, Peter Schneider, Felix Mahfoud, Michael Moche, Jos van den Berg, Henrik Schröder
    1. -

      Introduction by the chairman

    2. -

      CORAL trial aftermath: What do we do now? Renal revascularisation in perspective

        Michael Jaff
    3. -

      Live case transmission from Teaneck

    4. -

      How to assess the hemodynamic importance of a renal artery stenosis

        Felix Mahfoud
    5. -

      Endovascular treatment of mesenteric angina: Tips, tricks, and techniques

        Chris Metzger
    6. -

      Live case transmission from Teaneck

    7. -

      Visceral artery aneurysms. The silent killer comes into focus now that we can find them and fix them

        Michael Dake
    8. -

      Discussion and conclusion

  • Wednesday, January 28th: - , Main Arena 1

    The last frontiers: Interventional treatment of the popliteal artery

    Chairman:
    Jörn Balzer, Tony Das
    Moderator:
    Patrick Peeters, Peter Gaines, Reza Ghotbi, Lawrence Garcia, Eberhard Wedell
    1. -

      Balloon, DCB or stent? What is standard of interventional treatment in the popliteal artery?

        Martin Werner
    2. -

      The utility of the retrograde proximal anterior tibial access for challenging femoropopliteal occlusions

        Michael Piorkowski
    3. -

      Live case transmission from Leipzig

    4. -

      1 year results of the Gore TIGRIS® vascular stent in femoropopliteal lesions

        Martin Werner
    5. -

      Treatment of popliteal aneurysms: Endo or open?

        Jürgen Verbist
    6. -

      Live case transmission from Münster

  • Thursday, January 29th: - , Main Arena 1

    Innovative approaches and hot topics in endovascular interventions

    Chairman:
    Lawrence Garcia
    Moderator:
    Koen Deloose, Josef Tacke, Michael Lichtenberg, William Gray, Sigrid Nikol, Lieven Maene, Erich Minar
    1. -

      Does stent design influence the results of SFA stenting?

        Koen Deloose
    2. -

      New approaches for drug-eluting stents: The NitiDES programme

        Dierk Scheinert
    3. -

      Recorded case via satellite from Münster

    4. -

      Results from the Freeway Stent study

        Josef Tacke
    5. -

      ILLUMENATE Direct: 12 months results with direct DCB use in femoropopliteal arteries

        Stephan Duda
    6. -

      Next generation DCB coating–the EffPac-trial

        Sebastian Sixt
    7. -

      Live case transmission from Bad Krozingen

    8. -

      RELINE-trial: 24 months results with the Viabahn vs. PTA for in-stent restenosis

        Koen Deloose
    9. -

      The role of DCB for SFA-ISR

        Yann Gouëffic
    10. -

      First experience with DCB in AV-fistulas

        Stephan Duda
    11. -

      The utility of carbon-dioxide angiography in peripheral interventions

        Ulf Teichgräber
    12. -

      Using ARROW GPSCath to protect wire placement, reduce fluoroscopy while minimizing contrast

        Michael Lichtenberg
    13. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    Symposium: Individually excellent, together outstanding? Is DEB plus Stent the future for SFA therapy?

    Chairman:
    Marc van Sambeek
    Moderator:
    Francesco Liistro, Michael Lichtenberg, Paul Myers, Koen Deloose, Peter Soukas
    1. -

      Introduction by the chairman

    2. -

      Proven: Pulsar stent technology

        Michael Lichtenberg
    3. -

      Live case transmission from Bad Krozingen

    4. -

      Proven: Passeo-18 Lux drug releasing balloon technology

        Paul Myers
    5. -

      Live case transmission from Leipzig

    6. -

      Proven? Combining DEB and stent

        Koen Deloose
    7. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    Symposium: Clearing a path for the effective treatment of complex arterial and venous disease

    Chairman:
    Dierk Scheinert, William Gray
    Moderator:
    Mario Galli, Gerard O'Sullivan
    1. -

      Introduction and learning objectives

    2. -

      An open toolbox and open questions – where are we in Europe with drug elution, atherectomy and thrombectomy in 2015

        Dierk Scheinert
    3. -

      The utility of atherectomy and the Jetstream™ atherectomy system

        William Gray
    4. -

      Live case transmission from Bad Krozingen

    5. -

      Reducing thrombotic burden in arterial interventions

        Mario Galli
    6. -

      The importance of thrombectomy and stenting in venous intervention – case reviews and Angiojet™ AVX Thrombectomy™ system

        Gerard O'Sullivan
    7. -

      Closing and take home messages

  • Thursday, January 29th: - , Main Arena 1

    Lunch

  • Thursday, January 29th: - , Main Arena 1

    Latest insights from cardiovascular clinical trials

    Chairman:
    William Gray
    Moderator:
    Felix Mahfoud, Dietrich Pfeiffer, Dariusz Dudek, Joachim Schofer, Christian Etz
    1. -

      After SIMPLICITY III: Is there a future for catheter-based therapy of arterial hypertension?

        Michael Böhm
    2. -

      Review of results of the European, randomized trial of AV anastomosis with the ROX coupler for resistant hypertension

        Paul Sobotka
    3. -

      Live case transmission from Leipzig Heartcenter

    4. -

      The role of TAVI in high-risk and normal-risk patients

        Joachim Schofer
    5. -

      Echocardiographic criteria for favourable TAVI outcome – can we predict the risk?

        Andreas Hagendorff
    6. -

      Cerebral protection during TAVI – the CLEAN-TAVI trial

        Stephan Haußig
    7. -

      Live case transmission from Leipzig

    8. -

      Stroke prevention in patients with atrial fibrillation: When and how to use left atrium appendix closure?

        Dietrich Pfeiffer
    9. -

      Current status of ablation therapy for atrial fibrillation

        Philipp Sommer
    10. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    Symposium: Sustained embolic protection – shifting paradigms in carotid artery stenting?

    Chairman:
    Piotr Odrowaz-Pieniazek
    Moderator:
    Marco Roffi, Giovanni Torsello, Antonio Micari
    1. -

      The concept of Roadsaver carotid micromesh stent

        Stefan Müller-Hülsbeck
    2. -

      Live case transmission from Münster

    3. -

      Future perspectives of micromesh stents

        Antonio Micari
    4. -

      Clinical evidence for Roadsaver carotid stent – the CLEAR-ROAD Trial

        Koen Deloose
    5. -

      What can we learn from our real-world CAS practice?

        Maria Antonella Ruffino
    6. -

      Roadsaver – the optimal solution for all carotid lesions?

        Giovanni Torsello
    7. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    The last frontiers: Endovascular treatment of common femoral artery lesions and pioneering solutions for TASC D+ lesions

    Chairman:
    Patrick Peeters, Sebastian Debus
    Moderator:
    Sebastian Sixt, Chris Metzger, Paul Myers, Jihad Mustapha, Keisuke Hirano
    1. -

      Available techniques and outcome of endovascular procedures in the common femoral artery

        Thomas Zeller, Via satellite from Bad Krozingen
    2. -

      Live case transmission from Bad Krozingen

    3. -

      Surgical techniques for optimal reconstruction of the common femoral and external iliac segment

        Sebastian Debus
    4. -

      The value of hybrid procedures through the common femoral artery open access

        Daniela Branzan
    5. -

      Live case transmission from Leipzig

  • Friday, January 30th: - , Main Arena 1

    Critical issues in aortic endografting

    Chairman:
    Vicente Riambau
    Moderator:
    Reza Ghotbi, Piergiorgio Cao, Frank Veith, Armando Lobato, Giovanni Torsello
    1. -

      Live case transmission from Münster

    2. -

      Renaissance of the tube in EVAR – infrarenal double tubing with endo anchor augmentation

        Johannes Gahlen
    3. -

      Innovative device design and delivery sytems – exploring current and future device capabilities

        Dittmar Böckler
    4. -

      Total endovascular aortic arch replacement with the sandwich technique

        Armando Lobato
    5. -

      Long-term results of chimneys and sandwich grafts in the aortic arch

        Ralf Kolvenbach
    6. -

      Concurrent comparison between hypogastric artery interruption, bell- bottom and sandwich techniques: Long-term follow-up

        Armando Lobato
    7. -

      EVAR is better than open repair for ruptured AAAs despite recent level one evidence: IMPROVE, AJAX & ECAR are misleading

        Frank Veith
    8. -

      Improving care of patients with ruptured AAA: lessons from the USA and the UK

        Matt Thompson
    9. -

      One hundred percent of ruptured abdominal aortic aneurysms can be treated endovascularly if adjunctive techniques are used

        Thomas Larzon
    10. -

      Live case transmission from Leipzig

    11. -

      How to implement a successful programme for EVAR of ruptured aneurysms

        Zoran Rancic
    12. -

      Management of aortic disease in the state of infection or inflammation

        Martin Malina
    13. -

      Experience with re-do procedures in patients with infected endovascular or surgical aortic grafts

        Olaf Richter
    14. -

      Re-do procedures after stent-graft migration or graft component disconnection

        Andreas Gussmann
    15. -

      When are stent-grafts a reasonable option for aneurysm patients with connective tissue disease?

        Vicente Riambau
    16. -

      Live case transmission from Münster

    17. -

      Discussion and conclusion

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

For more infos on the cookies we use and how you can manage them, please visit our cookie policy.

  • We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.